| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.097 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |